Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 10;5(5):e745.
doi: 10.1002/hsr2.745. eCollection 2022 Sep.

Semen parameters after SARS-CoV-2 infection: A literature review

Affiliations

Semen parameters after SARS-CoV-2 infection: A literature review

Kathrine Tufvesson et al. Health Sci Rep. .

Abstract

Background and aims: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is known to affect multiple organs by binding to angiotensin-converting enzyme 2 receptors and might therefore affect male fertility. This review aims to collect all original articles on the effects of SARS-CoV-2 infection on male fertility, including the duration of time after infection required for these effects to begin to manifest and recommend how clinicians should approach cases with a recent illness.

Methods: This review was developed according to the preferred reporting items for systematic reviews and meta-analyses guidelines. The search string was applied to four online databases-namely Pubmed, Embase, Medline, and the Cochrane COVID-19 Register-and screened using the online tool Covidence.org. Articles were eligible for inclusion if they were cohort studies involving a healthy male population diagnosed with COVID-19, each of whom had semen samples collected before and after the infection or two different semen samples collected after the diagnosis.

Results: Nine cohort studies were eventually included. Five articles had pre- and post-COVID-19 data while four had two sets of post-COVID-19 data. The three largest studies found a statistically significant decrease in all semen parameters when waiting less than 3 months from diagnosis before sample collection, and no significant differences in results when the ejaculate was analyzed more than 3 months after recovery. One study compared the COVID-19 patients with a control group and found a significant decrease in semen parameters in the COVID-19 group.

Conclusion: Spermatogenesis seems to be affected by SARS-CoV-2 infection, but the impact tends to reverse within 3-4 months. It is still unclear why male fertility is affected by SARS-CoV-2 infection, and it might be the result of several different components. Clinicians should consider recent SARS-CoV-2 infection as a possible reason for the low semen quality of patients' semen samples, and might therefore need to collect new samples after 4 months before further treatment.

Keywords: COVID‐19; SARS‐CoV‐2; male infertility; semen parameters; spermatogenesis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Preferred reporting items for systematic reviews and meta‐analysis flowchart illustrating the process of selecting the articles.
Figure 2
Figure 2
Results from Tables 1 and 2 showed together for each category, which illustrates the changes in the semen parameters over time in the eight articles with data. (A) Change in volume (ml), (B) change in sperm concentration (million/ml), (C) change in total motility (%), and (D) change in progressive motility (%). Reference is the references according to World Health Organization.

Comment in

  • Male Infertility.
    Niederberger C. Niederberger C. J Urol. 2023 Feb;209(2):430-431. doi: 10.1097/JU.0000000000003062. Epub 2022 Nov 16. J Urol. 2023. PMID: 36382507 No abstract available.

References

    1. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727‐33. - PMC - PubMed
    1. World Health Organization . Accessed January 4, 2022. https://covid19.who.int/
    1. Fraietta R, Pasqualotto FF, Roque M, Taitson PF. SARS‐COV‐2 and male reproductive health. JBRA Assist Reprod. 2020;24(3):347‐350. - PMC - PubMed
    1. Segars J, Katler Q, McQueen DB, et al. Prior and novel coronaviruses, coronavirus disease 2019 (COVID‐19), and human reproduction: what is known? Fertil Steril. 2020;113(6):1140‐1149. - PMC - PubMed
    1. ESHRE COVID‐ Working G, Gianaroli L, Ata B, et al. The calm after the storm: re‐starting ART treatments safely in the wake of the COVID‐19 pandemic. Hum Reprod. 2021;36(2):275‐282. - PMC - PubMed

LinkOut - more resources